- Report
- May 2024
- 135 Pages
Global
From €5714EUR$6,499USD£4,935GBP
- Report
- May 2024
- 139 Pages
Global
From €5714EUR$6,499USD£4,935GBP
- Report
- May 2024
- 130 Pages
Global
From €5714EUR$6,499USD£4,935GBP
- Report
- May 2024
- 140 Pages
Global
From €5714EUR$6,499USD£4,935GBP
- Report
- July 2022
- 131 Pages
Global
From €3957EUR$4,500USD£3,417GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2418EUR$2,750USD£2,088GBP
- Report
- August 2022
- 30 Pages
Global
From €2418EUR$2,750USD£2,088GBP
- Report
- August 2022
- 30 Pages
Global
From €2418EUR$2,750USD£2,088GBP
- Report
- March 2022
- 96 Pages
Global
From €6595EUR$7,500USD£5,695GBP
- Report
- October 2023
- 170 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- June 2024
- 180 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- November 2023
- 185 Pages
Global
From €3363EUR$3,825USD£2,904GBP
€3957EUR$4,500USD£3,417GBP
- Report
- October 2023
- 82 Pages
United States
From €2616EUR$2,975USD£2,259GBP
€3077EUR$3,500USD£2,658GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3297EUR$3,750USD£2,847GBP
- Report
- June 2023
- 159 Pages
Global
From €6595EUR$7,500USD£5,695GBP
- Report
- September 2022
- 159 Pages
Global
From €6595EUR$7,500USD£5,695GBP
- Report
- June 2024
- 160 Pages
Global
From €2198EUR$2,500USD£1,898GBP
- Report
- February 2024
- 135 Pages
Global
From €4177EUR$4,750USD£3,607GBP
- Report
- April 2023
- 110 Pages
Global
From €4177EUR$4,750USD£3,607GBP
- Report
- August 2022
- 122 Pages
Global
From €4177EUR$4,750USD£3,607GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more